Beta-cell expansion for therapeutic compensation of insulin resistance in type 2 diabetes.

Shimon Efrat
{"title":"Beta-cell expansion for therapeutic compensation of insulin resistance in type 2 diabetes.","authors":"Shimon Efrat","doi":"10.1080/15438600303731","DOIUrl":null,"url":null,"abstract":"<p><p>Insulin resistance is the primary cause of type 2 diabetes. However, if compensated by increased insulin production, insulin resistance by itself does not lead to overt disease. Type 2 diabetes develops when this compensation is insufficient, due to defects in beta-cell function and in regulation of the beta-cell mass. beta-Cell transplantation, as well as approaches that replenish or preserve the endogenous beta-cell mass, may facilitate the treatment of type 2 diabetes in patients requiring exogenous insulin.</p>","PeriodicalId":84926,"journal":{"name":"International journal of experimental diabesity research","volume":"4 1","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/15438600303731","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of experimental diabesity research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15438600303731","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Insulin resistance is the primary cause of type 2 diabetes. However, if compensated by increased insulin production, insulin resistance by itself does not lead to overt disease. Type 2 diabetes develops when this compensation is insufficient, due to defects in beta-cell function and in regulation of the beta-cell mass. beta-Cell transplantation, as well as approaches that replenish or preserve the endogenous beta-cell mass, may facilitate the treatment of type 2 diabetes in patients requiring exogenous insulin.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
β细胞扩增对2型糖尿病胰岛素抵抗的治疗补偿。
胰岛素抵抗是2型糖尿病的主要原因。然而,如果通过增加胰岛素产生来补偿,胰岛素抵抗本身不会导致显性疾病。当这种代偿不足时,由于β细胞功能和β细胞质量调节的缺陷而发展为2型糖尿病。β细胞移植,以及补充或保存内源性β细胞团的方法,可能有助于治疗需要外源性胰岛素的2型糖尿病患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Des(1-3)IGF-1 treatment normalizes type 1 IGF receptor and phospho-Akt (Thr 308) immunoreactivity in predegenerative retina of diabetic rats. Beta-cell expansion for therapeutic compensation of insulin resistance in type 2 diabetes. Ins1 gene up-regulated in a beta-cell line derived from Ins2 knockout mice. Effects of postnatal stress on the development of type 1 diabetes in bank voles (Clethrionomys glareolus). The effects of middle cerebral artery occlusion on central nervous system apoptotic events in normal and diabetic rats.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1